TY - JOUR
T1 - Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells
AU - Shibakura, Misako
AU - Niiya, Kenji
AU - Niiya, Masami
AU - Asaumi, Noboru
AU - Yoshida, Chikamasa
AU - Nakata, Yasunari
AU - Tanimoto, Mitsune
N1 - Funding Information:
This work was supported in part by a Grant-in-Aid for Young Scientists (B) (No. 14771350) (to M.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
PY - 2005/7
Y1 - 2005/7
N2 - We previously reported the induction of interleukin-8 (IL-8), one of the CXC chemokines, by all-trans retinoic acid (ATRA) in PL-21 and NB4 human myeloid leukemia cells, which may be implicated in APL differentiation syndrome that is a relatively frequent complication in patients with acute promyelocytic leukemia (APL) during treatment with ATRA. We, therefore, further investigated the effects of ATRA on the expression of chemokine family in NB4 cells and APL cells prepared from two APL patients. The RNase protection assay using a multi-probe template set for human chemokines revealed that ATRA induced gene expressions of a number of CC chemokines, such as monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α and MIP-1β in NB4 cells. Their antigen levels were also increased in the cultured media. APL cells prepared from two APL patients showed gene expression of chemokines, such as IL-8, MCP-1, MIP-1α, and MIP-1β when stimulated with ATRA in vitro. Furthermore, serum levels of IL-8, MIP-1β and RANTES were increased during the course of ATRA treatment in both APL patients who developed APL differentiation syndrome. These chemokines are all chemoattractants of particular inflammatory cell types, including neutrophils, monocytes and lymphocytes; therefore, the simultaneous induction of these chemokines after stimulation with ATRA may exacerbate the hyper-inflammation observed in ATRA-induced APL differentiation syndrome.
AB - We previously reported the induction of interleukin-8 (IL-8), one of the CXC chemokines, by all-trans retinoic acid (ATRA) in PL-21 and NB4 human myeloid leukemia cells, which may be implicated in APL differentiation syndrome that is a relatively frequent complication in patients with acute promyelocytic leukemia (APL) during treatment with ATRA. We, therefore, further investigated the effects of ATRA on the expression of chemokine family in NB4 cells and APL cells prepared from two APL patients. The RNase protection assay using a multi-probe template set for human chemokines revealed that ATRA induced gene expressions of a number of CC chemokines, such as monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein (MIP)-1α and MIP-1β in NB4 cells. Their antigen levels were also increased in the cultured media. APL cells prepared from two APL patients showed gene expression of chemokines, such as IL-8, MCP-1, MIP-1α, and MIP-1β when stimulated with ATRA in vitro. Furthermore, serum levels of IL-8, MIP-1β and RANTES were increased during the course of ATRA treatment in both APL patients who developed APL differentiation syndrome. These chemokines are all chemoattractants of particular inflammatory cell types, including neutrophils, monocytes and lymphocytes; therefore, the simultaneous induction of these chemokines after stimulation with ATRA may exacerbate the hyper-inflammation observed in ATRA-induced APL differentiation syndrome.
KW - APL differentiation syndrome
KW - ATRA
KW - Acute promyelocytic leukemia
KW - Chemokine
UR - http://www.scopus.com/inward/record.url?scp=20344400368&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20344400368&partnerID=8YFLogxK
U2 - 10.1016/j.leukres.2005.01.005
DO - 10.1016/j.leukres.2005.01.005
M3 - Article
C2 - 15927671
AN - SCOPUS:20344400368
SN - 0145-2126
VL - 29
SP - 755
EP - 759
JO - Leukemia Research
JF - Leukemia Research
IS - 7
ER -